PA

Parveen Altafmiya Malek

Active Director Director DIN 08789647
DIN 08789647 First appointment Jul 2020 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2020
Shareholding value •••• Premium profile

About Parveen Altafmiya Malek

Data last updated:

Parveen Altafmiya Malek is a Director at Numida Biocare Private Limited (since 2020). The company operates in Pharma. Numida Biocare Private Limited reported revenue of ₹9.27 Cr (FY 2025).

DIN 08789647
Primary Designation Director
Industry Pharma
First Appointment 11 Jul 2020
Oldest Company Age 6 yrs
Largest company Numida Biocare Private Limited · ₹9.27 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Numida Biocare Private Limited U24230GJ2020PTC114534
Director11 Jul 20202020₹9.27 Cr (FY 2025)Active

Board colleagues of Parveen Altafmiya Malek

Directorship timeline

Open interactive timeline →
Numida Biocare Private Limited
Premium access

Shareholding and investment profile for Parveen Altafmiya Malek

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Parveen Altafmiya Malek

Parveen Altafmiya Malek currently holds 1 directorship: Numida Biocare Private Limited (Director, since 11 Jul 2020, revenue ₹9.27 Cr (FY 2025)).

Parveen Altafmiya Malek was first appointed on 11 Jul 2020 as Director at Numida Biocare Private Limited.

The current boards of Parveen Altafmiya Malek's companies include Altafmiya Jahidmiya Malek (Numida Biocare Private Limited), Anantpur Harish Murty (Numida Biocare Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available